Form D · Biotechnology
CENERX BIOPHARMA INC
Cary, NC · CIK 0001344759
Offering snapshot reported Jun 15, 2012 · SEC filing
- Reported sold
- $5.15M Offering amount: $5.15M
- Investors reported
- 7 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 21, 2011 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$4,616,674 → $5,153,674
- Reported investors6 → 7
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 15, 2012 | Amendment | $5,153,674 | $537,000vs Nov 30, 2011 | 7 | SEC filing |
| Nov 30, 2011 | Initial | $4,616,674 | No comparison | 6 | SEC filing |
| Jan 10, 2011 | Amendment | $7,000,000 | $4,000,000vs Aug 11, 2010 | 5 | SEC filing |
| Dec 9, 2010 | Amendment | $6,000,000 | $3,000,000vs Aug 11, 2010 | 5 | SEC filing |
| Aug 11, 2010 | Initial | $3,000,000 | No comparison | 5 | SEC filing |
| Jan 19, 2010 | Initial | $3,500,000 | No comparison | 5 | SEC filing |
| Jun 16, 2009 | Initial | $4,000,001 | No comparison | 5 | SEC filing |
| Sep 29, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Nov 14, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-169397
Source: Form D, filed Jun 15, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Mark Baric | Director, Executive |
| Barry Brand | Director, Executive |
| Steven Elms | Director |
| Steve Elms | Director |
| Ting Pau Oei | Director |
| Arthur Pappas | Director |
| Anthony Sun | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
270 Cornerstone Dr Suite 103
Cary, NC, 27519
Cary, NC, 27519